You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The team plans to use the technique to study methylation in colorectal, breast, and endometrial cancers. The long-term goal is to use it to determine how methylation differs among cell types in mixed tissue samples.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.